导赤散加味治疗慢性前列腺炎110例

目的 了解导赤散加味对慢性前列腺炎的疗效。方法 应用导赤散为主组方,结合直肠指诊、化验检查进行综合分析,辨证加减用药、治疗慢性前列腺炎110例,并与口服环丙沙星片、回通淋丹组40例作对照。结果 治疗组近期治愈率36.4%,总有效率为91.0％,对照组近期治愈率仅15.0%,总有效率为72.5%,两组的有效率比较差异有显性（P＜0．05）。结论 导赤散加味治疗慢性前列腺炎有明显改善作用。     

102例脑血管疾病患者血清脂蛋白(a)的检测

本文采用免疫透射比浊法对58例脑出血患者和44例脑梗塞患者血清Lp(a)进行检测并与健康体检者进行分析比较,三者结果分别为336.0±168.7mg/L和350.7±173.1mg/L及184.1±132.2mg/L,患者血清Lp(a)较正常人明显升高(P<0.01),Lp(a)是脑血管疾病一种重要危险因子。     

经颅多普勒超声对原发性帕金森病和血管性帕金森综合征检查的临床意义

目的探讨经颅多普勒超声(TCD)对原发性帕金森病(IPD)和血管性帕金森综合征(VPS)的临床应用价值和意义。方法对81例IPD和32例VPS患者的TCD和颅脑CT的检查结果进行比较研究。结果IPD组81例中总异常血管支数为223支(30．59％);VPS组32例中总异常血管支数为163支(56．60％);异常形式两组均以左侧大脑中、后动脉血流速度减慢为主要特点。结论IPD和VPS患者均伴有脑部血流动力学改变,VPS组的异常率高于IPD组,异常特点是左侧血流速度显著慢于右侧。     

川芎嗪与前列腺素E1联合治疗慢性肺源性心脏病急性发作期疗效观察

目的 观察联用川芎嗪（ＬＴ）和前列素（ＰＧＥ４）治疗慢性肺源性心脏病（肺心病）急性发作期患者的临床疗效。方法 １０５例肺心病急性发作期患者随机分为治疗组（５４例）和对照组（５１例）,治疗组采用ＬＴ联合ＰＧＥ１治疗;对照组采用单纯ＰＧＥ１治疗。２组患者于治疗后１０ｄ测定血液流变学指标并进行疗效判定。结果 治疗组显效率（５９．２６％）明显高于对照组（３９．２２％）,２组比较具有显著差异（Ｐ〈０．０５）     

基于肠-肾轴理论浅析膳食纤维对慢性肾病的影响

慢性肾病(chronic kidney disease,CKD)可引起肠道菌群失调及肠道屏障功能受损,而肠道稳态的破坏有 利于肠源性毒素的产生及肠腔细菌、内毒素的易位,加重CKD的尿毒症毒性及全身性炎症。膳食纤维可靶向作用于 “肠-肾轴”,从而降低CKD的尿毒症毒素水平及减轻全身性炎症。膳食纤维有望成为治疗CKD的新策略。     

先天性心脏病患者血浆内皮素与内源性类洋地黄素水平测定及其意义

应用放射免疫方法测定 2 4例先天性心脏病 (CHD)患者血浆内皮素 - 1(ET - 1)及内源性类洋地黄素 (EDLF)水平。结果显示 :血浆ET - 1水平CHD组明显高于正常对照组 (P <0 .0 1) ,CHD -LR组明显高于CHD -RL组 (P <0 .0 1) ;血浆EDLF水平CHD组明显低于正常对照组 (P <0 .0 1) ,CHD -LR组略高于CHD -RL组 (P >0 .0 5)。提示ET - 1及EDLF在CHD的病理生理过程中起一定作用     

硬膜外阻滞复合全身麻醉用于慢性阻塞性肺病病人的临床效果

目的比较硬膜外阻滞复合全身麻醉或单纯全身麻醉对上腹部和胸腔内手术病人术后肺功能和肺部并发症的影响。方法24名伴有中度术后肺部并发症危险的慢阻肺病人,接受上腹部或胸腔内手术,随机分成单纯全身麻醉(GA组)和硬膜外阻滞复合全身麻醉(Epi-Ga组)两组。术后采用VRS法评定镇痛效果。根据临床症状和体征、X线胸片、血气分析和床旁肺功能测定评估是否发生肺部并发症。术前1d和术后3d内评估和记录上述指标。结果术毕,GA组病人平均(34±16)min苏醒,(67±22)min拔除气管导管;Epi-Ga组苏醒时间和拔管时间分别为(12±4)和(32±12)min。术后第1天和第2天,Epi-Ga组病人术后镇痛效果明显优于GA组(P<0.01)。术后第1天,Epi-Ga组病人的FVC、FEV1/FVC%和FEF25%-75%下降不如GA组显著(P<0.05)。GA组有4例需要纤维支气管镜协助吸痰,而Epi-Ga组则无一例需要。两组病人术后肺炎、肺不张、支气管痉挛和呼吸衰竭的发生率无显著差异。结论局麻药加阿片类药物硬膜外自控镇痛使病人术后更加舒适,且能够改善病人术后肺功能。尽管两组病人术后肺部并发症无明显差异,但硬膜外阻滞复合全身麻醉以及术后硬膜外自控镇痛确实能够方便慢阻肺病人的术后管理。     

胸腺因子D对实验性大鼠肝纤维化防治作用的研究

目的　研究胸腺因子D(TFD)的体内抗肝纤维化作用。方法　用四氯化碳 (CCL4 )复制大鼠肝纤维化模型 ;造模开始或造模 30d后予TFD ;实验结束后分别测定肝功能、纤维化指标 (Ⅲ型前胶原、透明质酸和层粘连素 )、肝组织中谷胱甘肽、超氧化物岐化酶及丙二醛含量 ,并作肝病理检查。结果　TFD可显著减轻CCl4 肝纤维化程度 ,能明显降低血清Ⅲ型前胶原、透明质酸、层粘连素和肝组织中丙二醛含量 ;显著提高谷胱甘肽和超氧化物岐化酶活性 ,改善肝功能 ,组织学检查亦显示具有抗肝纤维化作用。结论　TFD在体内具有抗肝纤维化的作用 ,可望用于肝纤维化的防治。     

A Clinicopathologic Series of 22 Cases of Tonsillar Granulomas

Objectives Tonsils are uncommonly affected by granulomatous inflammation, often with an obscure cause. This study attempts to elucidate the nature of tonsillar granulomatous inflammation. Design Retrospective clinicopathologic review. Methods Twenty‐two cases of tonsillar granulomas diagnosed between 1940 and 1999 were retrieved from the files of the Armed Forces Institute of Pathology. H&E slides and a series of histochemical stains were reviewed, and patient follow‐up was obtained. Results There were 11 males and 11 females, aged 7 to 64 years (mean, 29.9 y). Most of the cases presented bilaterally (n = 19) with sore throat, dysphagia, and/or nasal obstruction. The clinical differential included chronic tonsillitis, tuberculosis, nonspecific infection, sarcoidosis, and a neoplasm. Histologically, the granulomas were focal and scattered, or diffuse, identified in the interfollicular zones (n = 16) and/or the germinal centers (n = 13), and occasionally associated with necrosis (n = 6). Based on histochemical and clinical follow‐up information, the etiology of the granulomas included sarcoidosis (n = 8), tuberculosis (n = 3), Hodgkin's lymphoma (n = 2), toxoplasmosis (n = 1), squamous cell carcinoma (n = 1), and no specific known cause (n = 7). Twelve patients were either alive at last follow‐up or had died with no evidence of disease (mean, 12.4 y), and 9 were either alive at last follow‐up or had died with disease (mean, 24.9 y). One patient was alive with unknown disease status (lost to follow‐up after 13.3 y). Conclusions Although a cause for tonsillar granulomas is frequently identified, a number may not develop an identifiable etiology, with the granulomas probably representing an exaggerated immune response to chronic tonsillitis. However, a careful work‐up must be conducted to exclude specific causes and avoid clinical mismanagement.     

Pressure Transfer Between Intracranial and Cochlear Fluids in Patients With Meniere's Disease

Objectives: To elucidate the pressure transfer between intracranial and labyrinthine fluids in patients with well‐defined unilateral Meniere's disease. Study Design: Eleven patients previously exposed to hypobaric pressure agreed to be investigated further with the tympanic membrane displacement (TMD) technique. TMD was used to indirectly analyze perilymph pressure changes as the result of changes in body position. Methods: Repeated measurements for both the diseased and the healthy ears were made with the patients supine and then in a sitting position. The TMD parameters for the maximum inward displacement, the Vi, and the mean volume displacement, the Vm, were calculated and compared. Results: The paired comparison showed statistically significant larger Vi values for both ears in the supine position. A similar tendency was observed for the Vm value. This difference of the Vi was significantly larger for the diseased ear compared with the currently healthy ear. The results were compared to the audiometric and electrocochleographic results previously obtained on the same patients when they were subjected to hypobaric pressure. Patients who experienced the largest differences in hearing level thresholds in the lower frequencies also showed the greatest differences in TMD values as the result of postural changes. Conclusions: Despite the limited number, the statistically supported results suggest a relation between the efficiency of the routes of pressure transfer and the observed effect of hypobaric exposure. The results also indicate that for the patients tested, the routes of communication are more effective in the diseased ear than in the healthy ear—a condition that may relate to the pathogeneses of Meniere's disease.